Advertisement

Topics

IRIS Company Profile

16:27 EDT 19th September 2018 | BioPortfolio

iris inc. is a professional consulting company specializing in integrated document management and data processing technology for the pharmaceutical industry. Our goal is to guide and support our clientele through the challenges of business re-engineering to achieve the goal of a successful implementation in time and within budget. Guaranteeing this service is our commitment to our clients.

Location

665 BroadwaySuite 502
New york city
New York
10012-2331
United States of America

Contact

Phone: 1 (212) 228-8800
Fax: 1 (212) 228-8835
Email: sales@teamiris.com


News Articles [38 Associated News Articles listed on BioPortfolio]

FDA OKs First Artificial Iris for Aniridia, Other Iris Defects

The CustomFlex Artificial Iris treats adults and children with congenital aniridia or iris defects due to other reasons or conditions, such as albinism, traumatic injury, or surgical removal due to me...

FDA approves first artificial iris

FDA approves first artificial iris, a surgically implanted device to treat aniridia or other damage to the iris

FDA approves first stand-alone prosthetic iris in the U.S.

The U.S. Food and Drug Administration today approved the first stand-alone prosthetic iris in the United States, a surgically implanted device to treat adults and children whose iris (the colored part...

FDA Approves Stand-Alone Artificial Iris

The FDA has approved the first stand-alone prosthetic iris for patients with damaged or completely missing irises. It is indicated for adults and children...

First Artificial Iris Approved

Following the recent approval by the US Food and Drug Administration (FDA) of the first artificial iris, Dr Brandon Ayres describes this groundbreaking solution for patients. Wills Eye Hospital

California Once Targeted Latinas for Forced Sterilization

(Smithsonian) – Iris’ participation in the World War II effort made her part of a celebrated time in U.S. history, when economic opportunities opened up for women and youth of color. However, ...

HumanOptics' artificial iris wins FDA nod

HumanOptics obtained premarket approval and a breakthrough device designation from the FDA for its CustomFlex artificial iris -More- 

First Artificial Iris is Approved

WEDNESDAY, May 30, 2018 -- The first artificial iris to replace the colored section of the eye that surrounds the pupil has been approved by the U.S. Food and Drug Administration. Many people who are ...

Drugs and Medications [77 Associated Drugs and Medications listed on BioPortfolio]

Miochol e [Bausch & Lomb Incorporated]

Miochol-E

Miochol e [Novartis Pharmaceuticals Corporation]

Miochol

Tamsulosin hydrochloride [Sandoz Inc]

These highlights do not include all the information needed to use tamsulosin hydrochloride capsules, USP safely and effectively. See full prescribing information for tamsulosin hydrochloride capsules,...

Tamsulosin hydrochloride [Preferred Pharmaceuticals, Inc]

These highlights do not include all the information needed to use tamsulosin hydrochloride safely and effectively. See full prescribing information for tamsulosin hydrochloride. Tamsulosin Hydrochlori...

Tamsulosin hydrochloride [American Health Packaging]

These highlights do not include all the information needed to use tamsulosin hydrochloride safely and effectively. See full prescribing information for tamsulosin hydrochloride. Tamsulosin Hydrochlori...

PubMed Articles [70 Associated PubMed Articles listed on BioPortfolio]

Aberrant plasma MMP and TIMP dynamics in Schistosoma - Immune reconstitution inflammatory syndrome (IRIS).

Among the different faces of immune reconstitution inflammatory syndrome (IRIS) developing in HIV-patients, no clinical definition has been reported for Schistosomiasis-IRIS (Schisto-IRIS). Although S...

Numerical stress analysis of the iris tissue induced by pupil expansion: Comparison of commercial devices.

(1) To use finite element (FE) modelling to estimate local iris stresses (i.e. internal forces) as a result of mechanical pupil expansion; and to (2) compare such stresses as generated from several co...

Assessing endocrine and immune parameters in human immunodeficiency virus-infected patients before and after the immune reconstitution inflammatory syndrome.

Objective The present study compares immune and endocrine parameters between HIV-infected patients who underwent the Immune Reconstitution Inflammatory Syndrome (IRIS-P) during antiretroviral therapy ...

Iris-claw intraocular lens for aphakia: Can location influence the final outcomes?

To describe the demographic data, evaluate the long-term refractive and anatomical outcomes, and report the incidence of complications of anterior iris (prepupillary) and posterior iris (retropupillar...

Short Axial Length and Iris Damage Are Associated With Iris Posterior Synechiae After Descemet Membrane Endothelial Keratoplasty in Asian Eyes.

To evaluate the frequency and severity of iris posterior synechiae after Descemet membrane endothelial keratoplasty (DMEK) and to investigate possible causes of iris posterior synechiae.

Clinical Trials [78 Associated Clinical Trials listed on BioPortfolio]

Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects

The purpose of this study is to evaluate the safety and effectiveness of an artificial iris prosthesis for the treatment of iris defects.

Sympathetic-parasympathetic Ratio of Our Gaze

ABSTRACT BACKGROUND The existence of the retinohypothalamic pathway suggests that light may influence autonomic outflow activity. The objective of this study was to examine the correlation...

A Pilot Study for the Treatment of Iris Neovascularization With Macugen

The purpose of this study is to determine if a drug called Macugen may help to stop the growth of abnormal blood vessels on the iris that has occurred in the eye(s) as part of diabetic ret...

Annular Reshaping of the Mitral Valve for MR Using the Millipede IRIS System

Multi center evaluation of the Millipede IRIS for treatment of clinically significant mitral regurgitation in subjects determined appropriate for mitral valve surgery.

IRIS-Synergy Cohort in the IRIS-DES Registry

The purpose of this study is to evaluate the relative effectiveness and safety of Synergy stent compared to other drug eluting stents.

Companies [16 Associated Companies listed on BioPortfolio]

IRIS International, Inc.

IRIS International, Inc. is a leader in vitro diagnostic urinalysis systems, digital imaging software development, sample collection, sample processing and small benchtop centrifuges and supplies for ...

Iris Diagnostics

Iris Diagnostics, a division of IRIS International, Inc., manufactures and sells urinalysis systems for use in hospitals and commercial laboratories worldwide. These systems perform both chemistry and...

Iris Plans, Inc.

Iris Plans is a tech-enabled service that provides Advance Care Planning (ACP) to people with serious medical conditions. ACP’s benefits include higher quality care, less str...

International Research Institute of Stavanger AS (IRIS)

IRIS is an independent research institute with research and research related activities within Petroleum, Marine Environment, Gas Technology, Social Science and Business Development.

IRIS

iris inc. is a professional consulting company specializing in integrated document management and data processing technology for the pharmaceutical industry. Our goal is to guide and support our clien...

More Information about "IRIS" on BioPortfolio

We have published hundreds of IRIS news stories on BioPortfolio along with dozens of IRIS Clinical Trials and PubMed Articles about IRIS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of IRIS Companies in our database. You can also find out about relevant IRIS Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record